Back to search

Switzerland· 00687003

Berirab 2 ml, Injektionslösung

A rabies immunoglobulin product containing immunoglobulinum humanum anti-rabies, registered in Switzerland by CSL Behring AG and dispensed under Swissmedic category B. The same ATC class is registered in 5 of our 19 countries.

Cat B (Swissmedic)ATC J06BB05

Checked against Swissmedic (Switzerland) on

Informational only — not a medical device.

SOURCE REGISTER · CHSwissmedic (Switzerland)normalisedBerirab 2 ml, InjektionslösungATCJ06BB05REGISTER NO.00687003PACKS LISTED0CHECKEDSeptember 12, 2026

Where it is registered

Rabies immunoglobulin is registered in 5 of 19 countries.

Countries holding a registration under ATC J06BB05 (rabies immunoglobulin), each read from that country’s own register.

  • This record: Switzerland, from Swissmedic (Switzerland)
  • 3 of them publish a price we can compare per daily dose

Rabies immunoglobulin · ATC J06BB05

5 / 19 countries

  • Canada
  • Czechiaprice
  • Norwayprice
  • Switzerlandprice
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Swissmedic (Switzerland)
Active substance
immunoglobulinum humanum anti-rabies
Manufacturer
CSL Behring AG
Country
Switzerland (CH)
ATC code
J06BB05
ATC class
Rabies immunoglobulin
Swissmedic category
B
Reimbursed
No
Source register
Swissmedic (Switzerland)
Last checked
September 12, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Rabies immunoglobulin in 7 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All rabies immunoglobulin products

Authorised across Europe · EMA

The same active substance is authorised in 4 EEA countries. Names it is sold under:

  • Austria · Berirab P
  • Germany · Berirab
  • Spain · Hyperrab
  • United Kingdom (Northern Ireland) · Human Rabies Immunoglobulin Bio Products Laboratory

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swissmedic (Switzerland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/44e5a226-c26b-4896-8750-f5a8baa9e4f1
GET /v1/drugs/44e5a226-c26b-4896-8750-f5a8baa9e4f1?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{}

See everything about rabies immunoglobulin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.